Polyvinylpyrrolidone (PVP), a non-ionic polymer, has been employed in multifarious fields equivalent to paper, fibers and textiles, ceramics, and pharmaceutics resulting from its superior properties. Particularly in pharmacy, the properties of inertness, non-toxicity, and biocompatibility make it a flexible excipient for each standard formulations and novel managed or focused supply techniques, serving as a binder, coating agent, suspending agent, pore-former, solubilizer, stabilizer, and so on. PVP with completely different molecular weights (MWs) and concentrations is utilized in a wide range of formulations for various functions.
On this evaluate, PVP-related researches primarily in current 10 years have been collected, and its principal pharmaceutical functions have been summarized as follows: (i) bettering the bioavailability and stability of medicine, (ii) bettering the physicomechanical properties of preparations, (iii) adjusting the discharge charge of medicine, and (iv) prolonging the in vivo circulation time of liposomes. Most of those functions may very well be defined by the viscosity, solubility, hydrophilicity, and hydrogen bond-forming capability of PVP, and the particular motion mechanisms for every software have been additionally tried to determine.
The impact of PVP on bioavailability enchancment establishes it as a promising polymer within the rising managed or focused formulations, attracting rising curiosity on it. Subsequently, given its irreplaceability and large alternatives for future developments, this evaluate goals to offer an informative reference about present roles of PVP in pharmacy for readers. The understanding of drug-carrier interactions is important for the design and functions of metal-organic framework (MOF)-based drug supply techniques. Whereas such drug-carrier interactions will be basically completely different for MOFs with or with out defects.
On this work, we revealed that the defects in MOFs play a key function within the loading of many prescription drugs with phosphate or phosphonate teams. The host-guest interplay is dominated by the Coulombic attraction between phosphate/phosphonate teams and defect websites and it strongly enhances the loading capability. For comparable molecules and not using a phosphate/phosphonate group or for MOF with out defects, the loading capability is significantly diminished.
We employed solid-state nuclear magnetic resonance (NMR) and molecular simulations to elucidate the drug-carrier interplay mechanisms. By way of a synergistic mixture of experimental and theoretical analyses, the docking conformations of prescription drugs on the defects have been revealed. Subsequently, analysis on environmental conduct and management methods needs to be carried out together with assessing their persistent toxicity to establish potential human and ecological dangers.
Prevalence and unsafe impression of pharmaceutical and private care merchandise and antibiotics in atmosphere: A evaluate on rising contaminants
Antibiotic resistance is a world well being emergency linked to unrestrained use of pharmaceutical and private care merchandise (PPCPs) as prophylactic agent and therapeutic functions throughout varied industries. Prevalence of pharmaceuticalsare recognized in floor water, floor water, soils, and wastewater therapy vegetation (WWTPs) in ng/L to μg/L focus vary. The prevalence of natural compounds together with antimicrobial brokers, hormones, antibiotics, preservatives, disinfectants, artificial musks and so on. in atmosphere have posed critical well being considerations. The goal of this evaluate is to elucidate the main sources accountable for emergence of antibiotic resistance.
For this function, number of introductory sources and destiny of PPCPs in aquatic atmosphere together with human and veterinary wastes, aquaculture and agriculture associated wastes, and different anthropogenic actions have been mentioned. Moreover, genetic and enzymatic components accountable for switch and look of antibiotic resistance genes are introduced. Ecotoxicity of PPCPs has been studied in atmosphere in an effort to current danger imposed to human and ecological well being. As per printed literature experiences, the removing of antibiotics and associated traces being troublesome, {couples} the potential of emergence of antibiotic resistance and therefore sustainability in world water assets.
A Comparative Exploration of High quality Assurance Outcomes by the Third-Occasion Pharmaceutical Schooling Analysis in Japan
The Requirements for the Institution of Universities in Japan have been revised; subsequently, the variety of colleges or universities of pharmacy/pharmaceutical sciences elevated from 46 in 2002 to 74 in 2016.The pharmacy training programme was additionally modified from 4 to 6 years, which was carried out in 2006. On this examine, we offer the comparative outcomes of the primary cycle of the third-party accrediting group, the Japan Accreditation Board for Pharmaceutical Schooling (JABPE); Strategies: The outcomes of the primary cycle of all universities or colleges of pharmacy assessed by the JABPE from JABPE web site have been retrieved, and we collated and in contrast the outcomes based mostly on the 13 areas of the evaluation requirements; Outcomes:
In “enhancements”, the variety of public universities or colleges was lower than that of personal universities or colleges, and the variety of outdated non-public universities or colleges was additionally lower than the variety of new non-public universities or colleges in all evaluation areas. These outcomes counsel that new universities or colleges established since 2003 haven’t but established their very own high quality assurance mechanism throughout the establishments. We have to evaluate the Japanese pharmacy training system or the evaluation standards for it to result in important change. The biomarkers of stress and toxicity have been evaluated in digestive gland, besides the lysosomal membrane stability measured in hemocytes.
Exposures brought on an oxidative stress as a result of decreased SOD and GST actions and GSH/GSSG ratio, elevated ranges of thiobarbituric acid-reactive substances and protein carbonyls (with some exceptions). Dc elevated cathepsin D exercise in lysosomes. Nf elevated lysosomal membrane stability and caspase-Three exercise. Rn brought on a dramatic distortion of metallo-thiolome resulting from elevated ranges of GSH and metallothionein-related thiols (MTSH) in addition to depletion of Zn, Cu and Cd within the composition of metallothioneins, and decreased Zn/Cu molar ratio within the tissue.
 Antibody) Caspase 1 (p10, Cleaved-Ala317) Antibody |
|
20-abx015550 |
Abbexa |
-
EUR 314.00
-
EUR 98.00
-
EUR 398.00
-
EUR 495.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
|
 /P10 Antibody) Cleaved Caspase-1 (Arg317) /P10 Antibody |
|
AF4022 |
Affbiotech |
200ul |
EUR 376 |
|
Description: Caspase 1 (p10,Cleaved-Arg317) Antibody detects endogenous levels of fragment of activated Caspase 1 resulting from cleavage adjacent to Arg317. |
 Caspase 1 p10 Blocking Peptide |
|
20-abx062325 |
Abbexa |
|
|
|
|
/CASP3 Antibody) Anti-Caspase-3 (P10)/CASP3 Antibody |
|
PA1302 |
BosterBio |
100ug/vial |
EUR 294 |
Anti-Caspase-3 (P10)/CASP3 Antibody |
|
PA1302-2 |
BosterBio |
100ug/vial |
EUR 334 |
/CASP8 Antibody) Anti-Caspase-8(P10)/CASP8 Antibody |
|
PA1524 |
BosterBio |
100ug/vial |
EUR 334 |
 Antibody) Caspase 14 (p10, Cleaved-Lys222) Antibody |
|
20-abx015552 |
Abbexa |
-
EUR 314.00
-
EUR 98.00
-
EUR 398.00
-
EUR 495.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
|
 Antibody) Caspase 5 (p10, Cleaved-Ser331) Antibody |
|
20-abx015560 |
Abbexa |
-
EUR 314.00
-
EUR 98.00
-
EUR 398.00
-
EUR 495.00
|
- 100 ug
- 10 ug
- 200 ug
- 300 µg
|
|
|
 Caspase 5 p10 Blocking Peptide |
|
20-abx062339 |
Abbexa |
|
|
|
|
 Caspase 14 p10 Blocking Peptide |
|
20-abx063778 |
Abbexa |
|
|
|
|
 /P10 Blocking Peptide) Cleaved Caspase-1 (Arg317) /P10 Blocking Peptide |
|
AF4022-BP |
Affbiotech |
1mg |
EUR 195 |
 Polyclonal Antibody) Cleaved-Caspase-5 p10 (S331) Polyclonal Antibody |
|
ES1020-100ul |
ELK Biotech |
100ul |
EUR 279 |
|
Description: A Rabbit Polyclonal antibody against Cleaved-Caspase-5 p10 (S331) from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Cleaved-Caspase-5 p10 (S331) Polyclonal Antibody |
|
ES1020-50ul |
ELK Biotech |
50ul |
EUR 207 |
|
Description: A Rabbit Polyclonal antibody against Cleaved-Caspase-5 p10 (S331) from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Cleaved-Caspase-5 p10 (S331) Polyclonal Antibody |
|
ABP50021-003ml |
Abbkine |
0.03ml |
EUR 158 |
|
|
|
Description: A polyclonal antibody for detection of Cleaved-Caspase-5 p10 S331) from Human. This Cleaved-Caspase-5 p10 S331) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Caspase-5 p10 at AA range: 290-370 |
Cleaved-Caspase-5 p10 (S331) Polyclonal Antibody |
|
ABP50021-01ml |
Abbkine |
0.1ml |
EUR 289 |
|
|
|
Description: A polyclonal antibody for detection of Cleaved-Caspase-5 p10 S331) from Human. This Cleaved-Caspase-5 p10 S331) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Caspase-5 p10 at AA range: 290-370 |
Cleaved-Caspase-5 p10 (S331) Polyclonal Antibody |
|
ABP50021-02ml |
Abbkine |
0.2ml |
EUR 414 |
|
|
|
Description: A polyclonal antibody for detection of Cleaved-Caspase-5 p10 S331) from Human. This Cleaved-Caspase-5 p10 S331) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Caspase-5 p10 at AA range: 290-370 |
 antibody) Anti-Cleaved-Caspase-5 p10 (S331) antibody |
|
STJ90029 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Cleaved-Caspase-5 p10 (S331). |
Cleaved-Caspase-5 p10 (S331) Polyclonal Antibody |
|
40509-100ul |
SAB |
100ul |
EUR 252 |
Cleaved-Caspase-5 p10 (S331) Polyclonal Antibody |
|
40509-50ul |
SAB |
50ul |
EUR 187 |
/CASP1 Antibody) Anti-Caspase-1(P20)/CASP1 Antibody |
|
PA1440-1 |
BosterBio |
100ug/vial |
EUR 294 |
 Anti-Caspase 8/CASP8 Antibody |
|
A00042-1 |
BosterBio |
100ug/vial |
EUR 294 |
 Anti-Caspase-2/CASP2 Antibody |
|
A02384-1 |
BosterBio |
100ug/vial |
EUR 334 |
 Anti-Caspase 4/CASP4 Antibody |
|
A02941-1 |
BosterBio |
100ug/vial |
EUR 334 |
 Anti-Caspase-8 Rabbit Monoclonal Antibody |
|
M00042-1 |
BosterBio |
100ug/vial |
EUR 397 |
|
Description: Rabbit Monoclonal Caspase-8 Antibody. Validated in IF, WB and tested in Human. |
 Anti-Caspase-7 Rabbit Monoclonal Antibody |
|
M01044-1 |
BosterBio |
100ug/vial |
EUR 397 |
|
Description: Rabbit Monoclonal Caspase-7 Antibody. Validated in IP, WB and tested in Mouse, Rat. |
 Anti-Caspase-10 Rabbit Monoclonal Antibody |
|
M02190-1 |
BosterBio |
100ug/vial |
EUR 397 |
|
Description: Rabbit Monoclonal Caspase-10 Antibody. Validated in IP, WB and tested in Human. |
 Anti-Caspase-2 Rabbit Monoclonal Antibody |
|
M02384-1 |
BosterBio |
100ug/vial |
EUR 397 |
|
Description: Rabbit Monoclonal Caspase-2 Antibody. Validated in IF, IHC, WB and tested in Human, Mouse, Rat. |
/CASP6 Antibody) Anti-Caspase-6(P18)/CASP6 Antibody |
|
PA1441-1 |
BosterBio |
100ug/vial |
EUR 334 |
/CASP3 Antibody) Anti-Caspase-3(P17)/CASP3 Antibody |
|
PA1961-1 |
BosterBio |
100ug/vial |
EUR 334 |
 Caspase-1 Antibody |
|
24290-100ul |
SAB |
100ul |
EUR 390 |
Caspase-1 Antibody |
|
24291-100ul |
SAB |
100ul |
EUR 390 |
 caspase 1 Antibody |
|
39310-100ul |
SAB |
100ul |
EUR 390 |
Caspase-1 Antibody |
|
48847-100ul |
SAB |
100ul |
EUR 333 |
Caspase-1 Antibody |
|
48847-50ul |
SAB |
50ul |
EUR 239 |
 Caspase 1 Antibody |
|
AF5418 |
Affbiotech |
200ul |
EUR 304 |
|
Description: Caspase 1 Antibody detects endogenous levels of total Caspase 1. |
Caspase 1 Antibody |
|
6687-100 |
Biovision |
|
EUR 338 |
Caspase 1 Antibody |
|
6687-30T |
Biovision |
|
EUR 146 |
Caspase-1 Antibody |
|
3019-100 |
Biovision |
|
EUR 403 |
Caspase-1 Antibody |
|
3019-30T |
Biovision |
|
EUR 146 |
 Caspase 1 antibody |
|
20R-1427 |
Fitzgerald |
100 ug |
EUR 651 |
|
Description: Rabbit polyclonal Caspase 1 antibody |
Caspase 1 antibody |
|
70R-15367 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Rabbit polyclonal Caspase 1 antibody |
Caspase-1 Antibody |
|
3459-002mg |
ProSci |
0.02 mg |
EUR 171.82 |
|
|
|
Description: Caspase-1 Antibody: Caspases are a family of cysteine proteases that can be divided into the apoptotic and inflammatory caspase subfamilies. Unlike the apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens. Members of this subfamily include caspase-1, -4, -5, and -12 and can activate proinflammatory cytokines such as IL-1β and IL-18. Caspase-1 was initially identified as an IL-1β-converting enzyme; later experiments revealed it to be a mammalian homolog of the C. elegans cell death gene ced-3 whose overexpression can induce apoptosis in fibroblasts. |
Caspase-1 Antibody |
|
3459-01mg |
ProSci |
0.1 mg |
EUR 436.42 |
|
|
|
Description: Caspase-1 Antibody: Caspases are a family of cysteine proteases that can be divided into the apoptotic and inflammatory caspase subfamilies. Unlike the apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens. Members of this subfamily include caspase-1, -4, -5, and -12 and can activate proinflammatory cytokines such as IL-1β and IL-18. Caspase-1 was initially identified as an IL-1β-converting enzyme; later experiments revealed it to be a mammalian homolog of the C. elegans cell death gene ced-3 whose overexpression can induce apoptosis in fibroblasts. |
Caspase-1 Antibody |
|
3463-002mg |
ProSci |
0.02 mg |
EUR 171.82 |
|
|
|
Description: Caspase-1 Antibody: Caspases are a family of cysteine proteases that can be divided into the apoptotic and inflammatory caspase subfamilies. Unlike the apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens. Members of this subfamily include caspase-1, -4, -5, and -12 and can activate proinflammatory cytokines such as IL-1β and IL-18. Caspase-1 was initially identified as an IL-1β-converting enzyme; later experiments revealed it to be a mammalian homolog of the C. elegans cell death gene ced-3 whose overexpression can induce apoptosis in fibroblasts. |
Caspase-1 Antibody |
|
3463-01mg |
ProSci |
0.1 mg |
EUR 436.42 |
|
|
|
Description: Caspase-1 Antibody: Caspases are a family of cysteine proteases that can be divided into the apoptotic and inflammatory caspase subfamilies. Unlike the apoptotic caspases, members of the inflammatory subfamily are generally not involved in cell death but are associated with the immune response to microbial pathogens. Members of this subfamily include caspase-1, -4, -5, and -12 and can activate proinflammatory cytokines such as IL-1β and IL-18. Caspase-1 was initially identified as an IL-1β-converting enzyme; later experiments revealed it to be a mammalian homolog of the C. elegans cell death gene ced-3 whose overexpression can induce apoptosis in fibroblasts. |
Caspase 1 antibody |
|
70R-11561 |
Fitzgerald |
100 ug |
EUR 527 |
|
Description: Rabbit polyclonal Caspase 1 antibody |
Caspase 1 antibody |
|
70R-13979 |
Fitzgerald |
100 ug |
EUR 322 |
|
Description: Affinity purified Rabbit polyclonal Caspase 1 antibody |
Caspase 1 antibody |
|
70R-14061 |
Fitzgerald |
100 ug |
EUR 322 |
|
Description: Affinity purified Rabbit polyclonal Caspase 1 antibody |
Caspase 1 antibody |
|
70R-31086 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Rabbit polyclonal Caspase 1 antibody |
Caspase 1 antibody |
|
70R-31087 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Rabbit polyclonal Caspase 1 antibody |
Caspase 1 antibody |
|
70R-31116 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Rabbit polyclonal Caspase 1 antibody |
Caspase 1 antibody |
|
70R-49451 |
Fitzgerald |
100 ul |
EUR 244 |
|
Description: Purified Polyclonal Caspase 1 antibody |
Caspase 1 antibody |
|
70R-49452 |
Fitzgerald |
100 ul |
EUR 244 |
|
Description: Purified Polyclonal Caspase 1 antibody |
Caspase 1 antibody |
|
70R-51474 |
Fitzgerald |
100 ul |
EUR 244 |
|
Description: Purified Polyclonal Caspase 1 antibody |
Caspase 1 antibody |
|
70R-35920 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Rabbit polyclonal Caspase 1 antibody |
 3-D Life RGD Peptide |
|
P10-3 |
Cellendes |
3x 1 µmol |
EUR 276 |
 Anti-pro Caspase 9 Rabbit Monoclonal Antibody |
|
M00080-1 |
BosterBio |
100ug/vial |
EUR 397 |
|
Description: Rabbit Monoclonal pro Caspase 9 Antibody. Validated in WB and tested in Human. |
 Anti-pro Caspase 3 Rabbit Monoclonal Antibody |
|
M00334-1 |
BosterBio |
100ug/vial |
EUR 397 |
|
Description: Rabbit Monoclonal pro Caspase 3 Antibody. Validated in IP, IF, WB and tested in Human, Mouse. |
 Anti-Caspase-6 p18 Rabbit Monoclonal Antibody |
|
M02631-1 |
BosterBio |
100ug/vial |
EUR 397 |
|
Description: Rabbit Monoclonal Caspase-6 p18 Antibody. Validated in IP, WB and tested in Human. |
 Caspase Inhibitor Set I |
|
A9901-1 |
ApexBio |
1 Set |
EUR 154 |
 Caspase-3/7 Inhibitor |
|
2780-1 |
Biovision |
|
EUR 153 |
 Caspase-3/7 Inhibitor I |
|
A1925-1 |
ApexBio |
1 mg |
EUR 148 |
|
Description: Caspase-3/7 inbibitor I is a potent, reversible, isatin sulfonamide-based inhibitor of caspase-3 (KI(app) = 60 nM) and caspase-7 (KI(app) = 170 nM). Is a weaker inhibitor of caspase-9 (Ki(app) = 3.1 mM). |
 Caspase-1 Polyclonal Antibody |
|
ES7677-100ul |
ELK Biotech |
100ul |
EUR 279 |
|
Description: A Rabbit Polyclonal antibody against Caspase-1 from Human/Monkey. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Caspase-1 Polyclonal Antibody |
|
ES7677-50ul |
ELK Biotech |
50ul |
EUR 207 |
|
Description: A Rabbit Polyclonal antibody against Caspase-1 from Human/Monkey. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Caspase-1 Polyclonal Antibody |
|
ES8461-100ul |
ELK Biotech |
100ul |
EUR 279 |
|
Description: A Rabbit Polyclonal antibody against Caspase-1 from Human/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Caspase-1 Polyclonal Antibody |
|
ES8461-50ul |
ELK Biotech |
50ul |
EUR 207 |
|
Description: A Rabbit Polyclonal antibody against Caspase-1 from Human/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
 Antibody) Caspase 1 (CASP1) Antibody |
|
20-abx301352 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody) Caspase 1 (pS376) Antibody |
|
abx148922-100ug |
Abbexa |
100 ug |
EUR 439 |
|
|
Caspase-1 Polyclonal Antibody |
|
ES1850-100ul |
ELK Biotech |
100ul |
EUR 279 |
|
Description: A Rabbit Polyclonal antibody against Caspase-1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Caspase-1 Polyclonal Antibody |
|
ES1850-50ul |
ELK Biotech |
50ul |
EUR 207 |
|
Description: A Rabbit Polyclonal antibody against Caspase-1 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
 Anti-Caspase-1 Antibody |
|
A00048 |
BosterBio |
100ug |
EUR 432 |
|
Description: Rabbit Polyclonal Caspase-1 Antibody. Validated in IP, IF, IHC, WB and tested in Human, Mouse, Rat. |
Caspase 1 (CASP1) Antibody |
|
20-abx109605 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Caspase 1 (CASP1) Antibody |
|
20-abx100442 |
Abbexa |
-
EUR 411.00
-
EUR 133.00
-
EUR 1149.00
-
EUR 565.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Caspase 1 (CASP1) Antibody |
|
20-abx100443 |
Abbexa |
-
EUR 411.00
-
EUR 133.00
-
EUR 1149.00
-
EUR 565.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Caspase 1 (CASP1) Antibody |
|
20-abx100444 |
Abbexa |
-
EUR 425.00
-
EUR 133.00
-
EUR 1177.00
-
EUR 578.00
-
EUR 328.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Caspase 1 (CASP1) Antibody |
|
20-abx100445 |
Abbexa |
-
EUR 439.00
-
EUR 133.00
-
EUR 1247.00
-
EUR 592.00
-
EUR 328.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Caspase 1 (CASP1) Antibody |
|
20-abx100446 |
Abbexa |
-
EUR 467.00
-
EUR 133.00
-
EUR 1358.00
-
EUR 648.00
-
EUR 356.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Caspase 1 (CASP1) Antibody |
|
abx037580-100ug |
Abbexa |
100 ug |
EUR 391 |
|
|
Caspase 1 (CASP1) Antibody |
|
abx038263-100ug |
Abbexa |
100 ug |
EUR 391 |
|
|
Caspase 1 (CASP1) Antibody |
|
20-abx007565 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
|
 Caspase 1 p20 Antibody |
|
20-abx009515 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
|
Caspase 1 (CASP1) Antibody |
|
20-abx009516 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
|
Caspase 1 (CASP1) Antibody |
|
20-abx009517 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
|
Caspase 1 (CASP1) Antibody |
|
20-abx000918 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Caspase-1 Polyclonal Antibody |
|
ABP50851-003ml |
Abbkine |
0.03ml |
EUR 158 |
|
|
|
Description: A polyclonal antibody for detection of Caspase-1 from Human, Mouse, Rat. This Caspase-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Caspase-1 around the non-phosphorylation site of S376 |
Caspase-1 Polyclonal Antibody |
|
ABP50851-01ml |
Abbkine |
0.1ml |
EUR 289 |
|
|
|
Description: A polyclonal antibody for detection of Caspase-1 from Human, Mouse, Rat. This Caspase-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Caspase-1 around the non-phosphorylation site of S376 |
Caspase-1 Polyclonal Antibody |
|
ABP50851-02ml |
Abbkine |
0.2ml |
EUR 414 |
|
|
|
Description: A polyclonal antibody for detection of Caspase-1 from Human, Mouse, Rat. This Caspase-1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human Caspase-1 around the non-phosphorylation site of S376 |
Caspase-1 Polyclonal Antibody |
|
ABP56678-003ml |
Abbkine |
0.03ml |
EUR 158 |
|
|
|
Description: A polyclonal antibody for detection of Caspase-1 from Human, Monkey. This Caspase-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Caspase-1 at AA range: 270-350 |
Caspase-1 Polyclonal Antibody |
|
ABP56678-01ml |
Abbkine |
0.1ml |
EUR 289 |
|
|
|
Description: A polyclonal antibody for detection of Caspase-1 from Human, Monkey. This Caspase-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Caspase-1 at AA range: 270-350 |
Caspase-1 Polyclonal Antibody |
|
ABP56678-02ml |
Abbkine |
0.2ml |
EUR 414 |
|
|
|
Description: A polyclonal antibody for detection of Caspase-1 from Human, Monkey. This Caspase-1 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human Caspase-1 at AA range: 270-350 |
The actual toxicity of Rn was additionally attested by decreased lysosomal membrane stability and cholinesterase exercise. Canonical discriminant evaluation separated Rn-, Combine- and MixT-groups from the joint set of C-, Dc- and Nf-groups. Typically, compound-specific results have been expressed in U. tumidus responses to the mixtures, however in MixT-group some results have been specific or extraordinarily robust. Multi-marker method and integrative evaluation proved to be a useful gizmo for understanding potential future dangers to freshwater mussels below a mixture of xenobiotics and warming local weather.
